194 related articles for article (PubMed ID: 11731461)
1. Selective rescue of early haematopoietic progenitors in Scl(-/-) mice by expressing Scl under the control of a stem cell enhancer.
Sánchez MJ; Bockamp EO; Miller J; Gambardella L; Green AR
Development; 2001 Dec; 128(23):4815-27. PubMed ID: 11731461
[TBL] [Abstract][Full Text] [Related]
2. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors.
Sánchez M; Göttgens B; Sinclair AM; Stanley M; Begley CG; Hunter S; Green AR
Development; 1999 Sep; 126(17):3891-904. PubMed ID: 10433917
[TBL] [Abstract][Full Text] [Related]
3. The SCL gene specifies haemangioblast development from early mesoderm.
Gering M; Rodaway AR; Göttgens B; Patient RK; Green AR
EMBO J; 1998 Jul; 17(14):4029-45. PubMed ID: 9670018
[TBL] [Abstract][Full Text] [Related]
4. Rescue of the lethal scl(-/-) phenotype by the human SCL locus.
Sinclair AM; Bench AJ; Bloor AJ; Li J; Göttgens B; Stanley ML; Miller J; Piltz S; Hunter S; Nacheva EP; Sanchez MJ; Green AR
Blood; 2002 Jun; 99(11):3931-8. PubMed ID: 12010791
[TBL] [Abstract][Full Text] [Related]
5. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
6. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors.
Göttgens B; Nastos A; Kinston S; Piltz S; Delabesse EC; Stanley M; Sanchez MJ; Ciau-Uitz A; Patient R; Green AR
EMBO J; 2002 Jun; 21(12):3039-50. PubMed ID: 12065417
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.
Delabesse E; Ogilvy S; Chapman MA; Piltz SG; Gottgens B; Green AR
Mol Cell Biol; 2005 Jun; 25(12):5215-25. PubMed ID: 15923636
[TBL] [Abstract][Full Text] [Related]
8. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.
Pimanda JE; Silberstein L; Dominici M; Dekel B; Bowen M; Oldham S; Kallianpur A; Brandt SJ; Tannahill D; Göttgens B; Green AR
Mol Cell Biol; 2006 Apr; 26(7):2615-25. PubMed ID: 16537906
[TBL] [Abstract][Full Text] [Related]
10. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene.
Mikkola HK; Klintman J; Yang H; Hock H; Schlaeger TM; Fujiwara Y; Orkin SH
Nature; 2003 Jan; 421(6922):547-51. PubMed ID: 12540851
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
Elefanty AG; Robb L; Birner R; Begley CG
Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
[TBL] [Abstract][Full Text] [Related]
12. Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.
Ferreira R; Spensberger D; Silber Y; Dimond A; Li J; Green AR; Göttgens B
Mol Cell Biol; 2013 Mar; 33(6):1254-66. PubMed ID: 23319051
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ "knock-in" strategy.
Elefanty AG; Begley CG; Metcalf D; Barnett L; Köntgen F; Robb L
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11897-902. PubMed ID: 9751762
[TBL] [Abstract][Full Text] [Related]
14. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development.
Visvader JE; Fujiwara Y; Orkin SH
Genes Dev; 1998 Feb; 12(4):473-9. PubMed ID: 9472016
[TBL] [Abstract][Full Text] [Related]
15. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis.
Kallianpur AR; Jordan JE; Brandt SJ
Blood; 1994 Mar; 83(5):1200-8. PubMed ID: 8118024
[TBL] [Abstract][Full Text] [Related]
16. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
17. Chromatin structure and transcriptional regulation of the stem cell leukaemia (SCL) gene in mast cells.
Fordham JL; Göttgens B; McLaughlin F; Green AR
Leukemia; 1999 May; 13(5):750-9. PubMed ID: 10374880
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the Scl +19 enhancer increases the blood stem cell compartment without affecting the formation of mature blood lineages.
Spensberger D; Kotsopoulou E; Ferreira R; Broccardo C; Scott LM; Fourouclas N; Ottersbach K; Green AR; Göttgens B
Exp Hematol; 2012 Jul; 40(7):588-598.e1. PubMed ID: 22401818
[TBL] [Abstract][Full Text] [Related]
19. The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.
Ogilvy S; Ferreira R; Piltz SG; Bowen JM; Göttgens B; Green AR
Mol Cell Biol; 2007 Oct; 27(20):7206-19. PubMed ID: 17709394
[TBL] [Abstract][Full Text] [Related]
20. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb L; Lyons I; Li R; Hartley L; Köntgen F; Harvey RP; Metcalf D; Begley CG
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7075-9. PubMed ID: 7624372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
